Dr. Jon LaPook talks about the latest developments in the fight against Alzheimerโs
Jessica Moore talks with Dr. Jon LaPook, who reports on promising new treatments and possible early detection for Alzheimer'sย ...
Former Vice President of Investor Relations, Johnson Johnson
Search every verified Jessica Moore interview, podcast appearance, and on-the-record quote โ each transcript cross-checked by AI and human review to confirm speaker identity. Jessica Moore, formerly Vice President of Investor Relations at Johnson & Johnson, has been publicly sharing her personal journey of recovery from substance use. In an August 2025 interview, Moore stated that she has been in recovery since July 8, 2022, and described it as her only period of sobriety that was not court-ordered. She said she began using drugs at age 13 and that her motivation to stay clean increased with each milestone. Moore said she is currently pursuing a bachelor's degree to become a counselor, and that her goal is to help others as a peer recovery specialist, a role she learned about during her own treatment. Moore has also discussed her career in television news. In a 2017 interview, she recounted being told by a news director and executive producer that she did not have what it takes for a reporting job, a moment she described as devastating. She said the same man later sent her a congratulatory email after she achieved success. Moore advised that people should be willing to fail and that discouragement often comes from those who have not taken risks themselves.
“The recent FDA approvals of medications that can slow cognitive decline in early Alzheimer's patients represent a significant advancement, but they do not reverse or stabilize the disease. The next step is exploring whether administering these treatments before symptoms appear can actually prevent or delay the onset of...”
“Giving these medications before symptoms occur is a revolutionary approach, similar to prescribing statins after a heart attack rather than before. The idea of early intervention could transform how we manage Alzheimer's in the future.”
“The new antibodies that can remove amyloid from the brain and show effectiveness on PET scans are a breakthrough, but they still do not reverse or stabilize the disease. Their real promise lies in early detection and intervention.”
“Bill Gates has invested over $300 million into Alzheimer's research, emphasizing the role of AI in analyzing vast data sets to improve early diagnosis and develop targeted treatments. His involvement highlights the importance of private sector funding in public health innovation.”
Jessica Moore talks with Dr. Jon LaPook, who reports on promising new treatments and possible early detection for Alzheimer'sย ...
"Your Story, Your Voice" Jessica Moore - Region Five Recovery Advisory Council Series. For more information go toย ...
CBS New York Weekend News Anchor, Jessica Moore, talks distractions and detractors as you are building your career.
Sign in to search the full transcript archive, filter by topic, and access every quote from Jessica Moore.